PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Identifies how quickly the company is scaling its balance sheet (via acquisitions, expansions, or debt). Strong growth, accompanied by sound fundamentals, can support long-term intrinsic value—while disproportionate debt expansion or bloated intangible assets can signal elevated risk.
-1.12%
Cash & equivalents declining signals potential liquidity drain. Benjamin Graham would investigate if this is from strategic investments or operational shortfalls.
No Data
No Data available this quarter, please select a different quarter.
-1.12%
Declining total liquid assets may signal capital redeployment or liquidity concerns. Howard Marks would investigate the underlying causes.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.12%
Declining current assets may signal efficient working capital or liquidity concerns. Benjamin Graham would investigate the composition of the decline.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.12%
Declining total assets may signal asset sales or strategic downsizing. Seth Klarman would investigate the strategic rationale.
36.86%
AP up over 5% yoy – potential sign of delayed payments or aggressive working capital management. Philip Fisher demands clarity on vendor terms vs. revenue expansion.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
26.96%
Above 15% yoy – a notable jump. Philip Fisher demands clarity on how short-term liabilities are managed.
4.78%
Up to 5% yoy – small increase. Howard Marks questions if cash flow comfortably covers new interest.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
4.78%
Up to 5% yoy – small increase. Howard Marks questions if the firm's cash flow can handle incremental obligations.
No Data
No Data available this quarter, please select a different quarter.
10.65%
Above 10% yoy – large jump. Philip Fisher demands clarity on whether growth justifies the leverage.
382.94%
Above 5% yoy – more significant share issuance. Philip Fisher demands a strong ROI or else it's dilution.
-3.62%
Declining retained earnings signals net losses or large dividends. Seth Klarman would investigate the sustainability of dividend policy.
No Data
No Data available this quarter, please select a different quarter.
382.94%
Above 10% yoy – bigger jump. Philip Fisher demands clarity on unusual equity expansions.
-10.94%
Declining stockholders equity may signal losses or large distributions. Seth Klarman would investigate the underlying causes and sustainability.
-1.12%
Declining total capital may indicate asset sales or poor capital allocation. Howard Marks would investigate strategic implications.
No Data
No Data available this quarter, please select a different quarter.
4.78%
Up to 5% yoy – small increase. Howard Marks questions if coverage ratios remain comfortable.
4.98%
Up to 5% yoy – small net debt increase. Howard Marks questions if operating cash flow covers the incremental borrowing.